MMJ Recs

AUGUST 14, 2022

The state of Michigan legalized the use of medical marijuana with the passing of the Michigan Compassionate Care Initiative in November 2008. With the legalization of MMJ in Michigan, a wide range of MMJ products became available to patients. MMJ patients are allowed to purchase up to 2.5 Chronic pain.

Dispensary 52

Dispensary Chronic Pain Edibles Conditions 52

The Cannigma

MARCH 2, 2021

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. As of January, 2021, PTSD was by far the most-listed qualifying condition in the state, with 57,661 out of 107,371 patients.

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

MARCH 3, 2020

The purpose of this statement is to reiterate the Indiana State Nurses Association’s ( IS NA) support for the review and reclassification of marijuana’s status from a federal Schedule I controlled substances to facilitate urgently needed clinical research to inform patients and providers on the efficacy of marijuana and related cannabinoids.

Policy 105

Policy Research and Development Chronic Pain Cannabinoids 105

MMJ Recs

OCTOBER 10, 2022

Michigan’s Medical Marijuana Program ( the MMMP ), which was voted for in 2008 by residents of the state, has ensured the provision of high-quality MMJ treatment for those who need it ever since. Chronic pain. You must be an adult patient without a caregiver to do so. Rheumatoid arthritis. Crohn’s Disease.

Marijuana 52

Marijuana Programs Chronic Pain Conditions 52

Otherside Farms

JULY 4, 2022

Reduce Chronic Pain. CBC Isolate reduced osteoarthritis pain in 2011. In 2008, Italian and British scientists found that CBC Isolate and other cannabinoids are as effective against MRSA as antibiotics like Vancomycin. Benefits of using CBC isolate. CBC Isolate and THC created an entourage effect, according to a study.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

Veriheal

FEBRUARY 28, 2021

The last day of February, the 28th, or the 29th during a leap year is World Rare Disease Day and this day has been designated to help bring awareness to rare diseases as well as the impact they have on patients and their lives. Patients and family members are open to trying anything that might help.

Chronic Pain 52

Chronic Pain Events Therapy Treatment 52

Cannabis Law Report

OCTOBER 14, 2021

patients must register at Opticann.ca Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. CB4 Control: CBD/CBDA Rapid Acting Sublingual Filmstrip with Versafilm ® technology from IntelGenx. ’s advocacy.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

Veriheal

OCTOBER 27, 2020

Robert started his career with the NYPD back in 2008. Later that year, in 2018, Robert was diagnosed with chronic pain and also treated for Lyme disease. This is a point when a patient, human being, free American should have the right to access alternative legal medicines to dangerous prescription drugs.

Chronic Pain 103

Chronic Pain Cannabis Conditions Medicine 103

Cannabis Law Report

JULY 24, 2022

The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Nevertheless, the regulatory hurdles for researchers and patients are still extremely high. A total of 170 patients were treated under these licenses. Limited Medical Use”.

Research and Development 52

Research and Development Legalization Treatment Patients 52

Veriheal

OCTOBER 1, 2020

In 2004, cannabis was reclassified as a class C drug but was reinstated to Class B in 2008 following Prime Minister Gordon Brown’s decision to go against the advice offered up by the Advisory Council on the Misuse of Drugs. . As you can see, cannabis is classified as a class B drug alongside the likes of ketamine and amphetamines.

Legalization 96

Legalization Oil Medicine Media 96

Green Relief

FEBRUARY 20, 2018

I was first introduced to the topic of Epigenetics in 2008 at a business conference in Florida, and as a medical professional I was immediately intrigued. Using genetic information to formulate a unique cannabis blend can decrease the “trial and error” phase upon starting cannabis, and provide more consistency in improving patient outcomes.

Therapy 40

Therapy Cannabinoids Cannabis Terpenes 40

Project CBD

FEBRUARY 27, 2023

No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression. Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life.

THC 144

THC CBD Sleep Clinical Trials 144

The Cannigma

JANUARY 13, 2023

Chronic migraines can make it incredibly challenging to hold down a job. The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). The review, however, did not cover patient access to medicinal cannabis. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

Dr. Michele Ross

DECEMBER 11, 2018

Approximately 10 million patients in the United States have fibromyalgia, and 75-90% are women. Patients with lupus, osteoarthritis, and or rheumatoid arthritis are at higher risk of developing fibromyalgia. No research has suggested harm from using cannabis in fibromyalgia patients.

Research and Development 66

Research and Development Therapy Patients Treatment 66

The Cannigma

SEPTEMBER 12, 2021

Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. Many states that disagreed with the federal approach to cannabis started their own medical marijuana programs, and made it accessible for patients. in 2008, 12% in 2012 and 15% in 2018.

THC 98

THC Research and Development Cannabinoids CBD 98